San Diego, CA, United States of America

Gabriel Pascual

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 59(Granted Patents)


Location History:

  • Honolulu, HI (US) (1984 - 1985)
  • La Jolla, CA (US) (2013 - 2016)
  • San Diego, CA (US) (2012 - 2022)

Company Filing History:


Years Active: 1984-2022

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Gabriel Pascual: Innovator in Antibody Development

Introduction: Gabriel Pascual, an accomplished inventor based in San Diego, California, has made significant strides in the field of biotechnology, particularly in the development of antibodies targeting microtubule-associated protein tau. With a remarkable portfolio of 14 patents, Pascual's work has implications for diagnostics, prophylaxis, and therapeutic methods in addressing related diseases.

Latest Patents: Among his notable innovations, Pascual's most recent patents include inventions centered around antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau. These groundbreaking inventions not only describe the antibodies themselves but also emphasize associated diagnostic, prophylactic, and therapeutic methods utilizing these anti-tau antibodies. This work highlights the potential for advancing treatment options for conditions linked to tau, paving the way for new medical interventions.

Career Highlights: Throughout his career, Gabriel Pascual has collaborated with leading companies in the biotechnology sector, including Janssen Vaccines & Prevention B.V. and Crucell Holland B.V. His expertise and innovative approaches have established him as a noteworthy figure in his field. His contributions have been vital in bridging scientific research with practical medical applications, underscoring his role in advancing health solutions.

Collaborations: In his journey, Pascual has worked alongside talented colleagues such as Robert Anthony Williamson and Jehangir Wadia. These collaborations have fostered a dynamic exchange of ideas and expertise, enhancing the scope and impact of his research endeavors.

Conclusion: Gabriel Pascual's pioneering efforts in the realm of antibody development demonstrate his commitment to innovation and improving health outcomes. His extensive patent portfolio and collaborations with prominent companies and colleagues reflect his significant contribution to medical science. As he continues to push the boundaries of biotechnological advancements, Pascual remains a vital player in the ongoing quest for effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…